News | Treatment Planning | November 05, 2015

Accuray and RaySearch Announce Second Long-Term Collaboration Agreement

RayStation will be extended to include treatment planning for the TomoTherapy and CyberKnife systems

Accuray, RaySearch, collaboration agreement, treatment planning support, TomoTherapy, CyberKnife, radiation therapy

RayStation image courtesy of RaySearch Laboratories AB

November 5, 2015 — Accuray Inc. and RaySearch Laboratories AB announced an expansion on their existing relationship with the signing of a new long-term collaboration agreement for the integration of treatment planning support for the TomoTherapy and CyberKnife systems in the RayStation treatment planning system (TPS).

Accuray and RaySearch previously announced a long-term collaboration regarding the RayCare oncology information system.

Under the contract, Accuray will have the opportunity to offer RayStation to clinicians who use the TomoTherapy and CyberKnife system product portfolios. Current RayStation users report that the software provides multiple benefits including advanced treatment planning tools, leading workflow support, and an excellent user experience, all of which enhance treatment delivery flexibility within a radiation oncology department.

Accuray has an installed base of more than 500 TomoTherapy Systems and more than 300 CyberKnife Systems worldwide. Treatment planning support for TomoTherapy Systems in RayStation is targeted for release during 2016 and support for CyberKnife Systems for release during 2017.

The CyberKnife M6 Series robotic full-body radiosurgery system enables precise, high-quality, high-dose distributions to the patient with extreme accuracy over a minimum number of treatments, reducing side effects and preserving patients' quality of life. The TomoTherapy H Series efficiently enables physicians to customize treatment plans for the entire range of radiation therapy patients and disease types. Its design enables treatment plans to be delivered with integrated, daily computed tomography (CT) image guidance, enhancing accuracy and delivering highly precise, intensity-modulated radiation for optimal sparing of healthy tissue and critical structures.

For more information: www.accuray.com, www.raysearchlabs.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more